UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 (Exact Name of Registrant as Specified in its Charter) | Delaware | 82-2956404 | | --- | --- | | (State or other jurisdiction of | (I.R.S. Employer | | incorporation or organization) | Identification No.) | | 805 N. Whittington Parkway | | | Louisville, Kentucky | 40222 | | (Address of ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 FOR THE TRANSITION PERIOD FROM TO Commission File Number: 001-32236 ________________ COHEN & STEERS, INC. (Exact Name of Registrant as Specified in its Charter) ________________ Delaware 14- ...

PART I. FINANCIAL INFORMATION [Item 1. Financial Statements](index=2&type=section&id=Item%201.%20Financial%20Statements) Presents unaudited condensed consolidated financial statements for Colgate-Palmolive Company, including income, balance sheet, and cash flow statements [Condensed Consolidated Statements of Income](index=2&type=section&id=Condensed%20Consolidated%20Statements%20of%20Income) Details net sales and income for Q2 and H1 2025, showing slight sales growth in Q2 and income growth across both periods Condensed Consolidated Statements of Income (Unaudited) | (In Millions Except Per Share) | Three Months Ended June 30, | Six Months Ended June 30, | | :--- | :---: | :---: | :---: | :---: | | | **2025** | **2024** | **2025** | **2024** | | **Net sales** | **$5,110** | **$5,058** | **$10,021** | **$10,124** | | Cost of sales | 2,041 | 1,992 | 3,965 | 4,019 | | **Gross profit** | **3,069** | **3,066** | **6,056** | **6,105** | | Selling, general and administrative expenses | 1,963 | 1,939 | 3,861 | 3,855 | | Operating profit | 1,080 | 1,092 | 2,156 | 2,139 | | Income before income taxes | 1,007 | 1,010 | 1,959 | 1,977 | | **Net income attributable to Colgate-Palmolive Company** | **$743** | **$731** | **$1,433** | **$1,414** | | **Earnings per common share, basic** | **$0.92** | **$0.89** | **$1.77** | **$1.72** | | **Earnings per common share, diluted** | **$0.91** | **$0.89** | **$1.76** | **$1.71** | [Condensed Consolidated Balance Sheets](index=4&type=section&id=Condensed%20Consolidated%20Balance%20Sheets) Presents the company's financial position as of June 30, 2025, showing increases in total assets, liabilities, and equity Condensed Consolidated Balance Sheets (Unaudited) | (In Millions) | June 30, 2025 | December 31, 2024 | | :--- | :---: | :---: | | **Total current assets** | $5,996 | $5,317 | | Property, plant and equipment, net | 4,529 | 4,422 | | Goodwill | 3,696 | 3,272 | | **Total assets** | **$17,470** | **$16,046** | | **Total current liabilities** | $6,775 | $5,759 | | Long-term debt | 7,144 | 7,289 | | **Total liabilities** | **$16,418** | **$15,502** | | **Total equity** | **$1,052** | **$544** | | **Total liabilities and equity** | **$17,470** | **$16,046** | [Condensed Consolidated Statements of Cash Flows](index=5&type=section&id=Condensed%20Consolidated%20Statements%20of%20Cash%20Flows) Summarizes cash flows for H1 2025, noting decreased operating cash, increased investing cash use, and reduced financing cash use Condensed Consolidated Statements of Cash Flows (Unaudited) | (In Millions) | Six Months Ended June 30, | | :--- | :---: | :---: | | | **2025** | **2024** | | **Net cash provided by (used in) operations** | **$1,484** | **$1,671** | | **Net cash provided by (used in) investing activities** | **($560)** | **($304)** | | **Net cash provided by (used in) financing activities** | **($867)** | **($1,206)** | | Effect of exchange rate changes on Cash and cash equivalents | $62 | ($17) | | **Net increase (decrease) in Cash and cash equivalents** | **$119** | **$144** | | Cash and cash equivalents at beginning of the period | $1,096 | $966 | | **Cash and cash equivalents at end of the period** | **$1,215** | **$1,110** | [Notes to Condensed Consolidated Financial Statements](index=8&type=section&id=Notes%20to%20Condensed%20Consolidated%20Financial%20Statements) Provides detailed information on accounting policies, acquisitions, restructuring, legal contingencies, and tax matters, including the Prime100 acquisition - On April 30, 2025, the Company acquired Care TopCo Pty Ltd, owner of the Prime100 pet food business, for approximately **$301 million in cash**. This acquisition provides an entry into the fresh pet food category in Australia for the Hill's Pet Nutrition segment[40](index=40&type=chunk) - On July 31, 2025, the Board approved a new three-year Productivity Program expected to incur pre-tax charges of **$200 to $300 million**. The program aims to align organizational structure, optimize the supply chain, and reduce overhead costs[44](index=44&type=chunk) - The company is involved in several legal contingencies, including Brazilian tax matters (approx. **$108 million** and **$26 million** at issue), Talcum powder litigation (**384 cases** pending), and an ERISA matter which has been settled in principle[62](index=62&type=chunk)[66](index=66&type=chunk)[68](index=68&type=chunk)[74](index=74&type=chunk) - The effective income tax rate for Q2 2025 was **23.2%**, down from **24.1%** in Q2 2024. The company is evaluating the impact of the new "One Big Beautiful Bill Act" (OBBBA) tax legislation[101](index=101&type=chunk)[102](index=102&type=chunk) [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A)](index=31&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management discusses Q2 and H1 2025 performance, covering sales, profitability, and cash flow across product segments and geographies [Executive Overview and Outlook](index=31&type=section&id=Executive%20Overview%20and%20Outlook) Outlines the company's two product segments, anticipates continued macroeconomic challenges, and details strategies including a new Productivity Program - The company operates in two product segments: Oral, Personal and Home Care; and Pet Nutrition. Approximately **45% of Net Sales** come from emerging markets[109](index=109&type=chunk)[110](index=110&type=chunk) - A new three-year "Productivity Program" was approved on July 31, 2025, with projected pre-tax charges of **$200 to $300 million** to drive future growth and support the 2030 strategy[120](index=120&type=chunk) - The company expects continued challenges from inflation, high interest rates, and foreign currency volatility. Tariffs are estimated to add approximately **$75 million** in incremental gross costs in 2025[124](index=124&type=chunk)[125](index=125&type=chunk) [Results of Operations - Three Months Ended June 30, 2025](index=37&type=section&id=Results%20of%20Operations%20-%20Three%20Months%20Ended%20June%2030%2C%202025) Analyzes Q2 2025 performance, highlighting 1.0% net sales growth, a 70 basis point decrease in non-GAAP gross profit margin, and a 1% increase in non-GAAP diluted EPS Q2 2025 Net Sales Growth vs. Q2 2024 | Segment | Net Sales Growth (GAAP) | Organic Sales Growth (Non-GAAP) | | :--- | :---: | :---: | | Total Oral, Personal and Home Care | 0.2% | 1.7% | | Pet Nutrition | 3.8% | 2.0% | | **Total Company** | **1.0%** | **1.8%** | Q2 2025 vs. Q2 2024 Profitability (Non-GAAP) | Metric | Q2 2025 | Q2 2024 | Change | | :--- | :---: | :---: | :---: | | Gross Profit Margin | 60.1% | 60.8% | (70) bps | | Operating Profit | $1,089M | $1,118M | (3)% | | Operating Profit Margin | 21.3% | 22.1% | (80) bps | | Diluted EPS | $0.92 | $0.91 | +1% | - The decrease in non-GAAP Gross Profit Margin was primarily driven by significantly higher raw and packaging material costs (**420 bps**), partially offset by cost savings (**250 bps**) and higher pricing (**80 bps**)[141](index=141&type=chunk) [Results of Operations - Six Months Ended June 30, 2025](index=47&type=section&id=Results%20of%20Operations%20-%20Six%20Months%20Ended%20June%2030%2C%202025) Reviews H1 2025 performance, noting a 1.0% decrease in net sales, flat non-GAAP gross profit margin, and a 3% increase in non-GAAP diluted EPS YTD 2025 Net Sales Growth vs. YTD 2024 | Segment | Net Sales Growth (GAAP) | Organic Sales Growth (Non-GAAP) | | :--- | :---: | :---: | | Total Oral, Personal and Home Care | (2.0)% | 1.3% | | Pet Nutrition | 2.6% | 2.5% | | **Total Company** | **(1.0)%** | **1.6%** | YTD 2025 vs. YTD 2024 Profitability (Non-GAAP) | Metric | YTD 2025 | YTD 2024 | Change | | :--- | :---: | :---: | :---: | | Gross Profit Margin | 60.4% | 60.4% | 0 bps | | Operating Profit | $2,181M | $2,202M | (1)% | | Operating Profit Margin | 21.8% | 21.8% | 0 bps | | Diluted EPS | $1.83 | $1.78 | +3% | - Non-GAAP Gross Profit Margin was flat year-over-year, as significantly higher raw and packaging material costs (**340 bps**) were offset by cost savings (**230 bps**), higher pricing (**70 bps**), and favorable mix (**30 bps**)[186](index=186&type=chunk) [Liquidity and Capital Resources](index=58&type=section&id=Liquidity%20and%20Capital%20Resources) Examines liquidity and capital, noting an 11% decrease in operating cash flow, increased total debt, and a higher quarterly dividend - Net cash provided by operations decreased **11%** to **$1,484 million** in the first six months of 2025, compared to **$1,671 million** in the same period of 2024[225](index=225&type=chunk) - In April 2025, the Company issued **$500 million** of five-year Senior Notes at a fixed coupon rate of **4.20%**[230](index=230&type=chunk) - The quarterly common stock dividend was increased to **$0.52 per share** from **$0.50 per share**, effective in the second quarter of 2025[233](index=233&type=chunk) [Item 3. Quantitative and Qualitative Disclosures About Market Risk](index=62&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) Reports no material changes in market risk disclosures concerning foreign currency, interest rate, commodity price, and credit exposures - There have been no material changes in market risk disclosures since the last Annual Report on Form 10-K[241](index=241&type=chunk) [Item 4. Controls and Procedures](index=63&type=section&id=Item%204.%20Controls%20and%20Procedures) Management concluded disclosure controls and procedures were effective as of June 30, 2025, with IT system upgrades not materially impacting internal controls - The CEO and CFO concluded that the Company's disclosure controls and procedures are effective as of June 30, 2025[243](index=243&type=chunk) - The company is upgrading its enterprise IT system and transitioning to the cloud, but this is not expected to materially affect internal control over financial reporting[244](index=244&type=chunk) PART II. OTHER INFORMATION [Item 1. Legal Proceedings](index=64&type=section&id=Item%201.%20Legal%20Proceedings) Refers to Note 10 of the Condensed Consolidated Financial Statements for detailed information on legal matters - For information on legal proceedings, the report refers to Note 10, Contingencies to the Condensed Consolidated Financial Statements[248](index=248&type=chunk) [Item 1A. Risk Factors](index=64&type=section&id=Item%201A.%20Risk%20Factors) States no material changes to risk factors previously disclosed in the 2024 Annual Report on Form 10-K - There have been no material changes to the risk factors disclosed in the company's 2024 Annual Report on Form 10-K[249](index=249&type=chunk) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=65&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) Details the new $5 billion share repurchase program authorized in March 2025 and Q2 2025 repurchase activity - A new **$5 billion** share repurchase program (the "2025 Program") was authorized on March 20, 2025[251](index=251&type=chunk) Share Repurchase Activity for Q2 2025 | Month | Total Shares Purchased | Average Price Paid per Share | Approx. Dollar Value Remaining (in millions) | | :--- | :---: | :---: | :---: | | April 2025 | 621,081 | $92.49 | $4,917 | | May 2025 | 722,695 | $90.45 | $4,852 | | June 2025 | 1,216,973 | $89.83 | $4,744 | | **Total Q2** | **2,560,749** | **$90.65** | **$4,744** | [Item 5. Other Information](index=66&type=section&id=Item%205.%20Other%20Information) Reports the Chief Legal Officer's Rule 10b5-1 trading plan for up to 6,000 shares, with no other similar arrangements by directors or officers - The Chief Legal Officer and Secretary, Jennifer M. Daniels, entered into a Rule 10b5-1 trading plan on May 1, 2025, for the sale of up to **6,000 shares**[256](index=256&type=chunk)

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 1, 2025 STRAN & COMPANY, INC. | (Exact name of registrant as specified in its charter) | | | | --- | --- | --- | | Nevada | 001-41038 | 04-3297200 | | (State or other jurisdiction | (Commission File Number) | (IRS Employer | | of incorporation) | | Identification No.) | | 2 Heritage Driv ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 27, 2025 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to _____________ Commission File Number: 001-39675 ALLEGRO MICROSYSTEMS, INC. (Exact name of registrant as specified in its charter) Delaware 46-2405937 (State ...

Rising markets proved quite favorable to our Wealth Management business revenue, with the rally driving assets under management ("AUM") to a fresh record, resulting in higher asset-based advisory fees when compared with the prior year period. Retail trading volumes, driven by investor interest, also remained robust, boosting commission revenue. However, the fees we earn on our FDIC sweep program are reduced from the prior year period due to lower deposit balances as clients sought higher returns in money ma ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-34774 Cboe Global Markets, Inc. (Exact Name of Registrant as Specified in Its Charter) (State or Other Jurisdiction of (I ...

Table of Contents OR UNITED STATES SECURITIES AND EXCHANGE COMMISSION ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Washington, D. C. 20549 For the transition period from to FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2025 Commission File Number 1-12043 OPPENHEIMER HOLDINGS INC. (Exact name of registrant as specified in its charter) (State or other jurisdict ...

We are reconfirming all guidance metrics for our Liberty Telecom operations while raising Telenet's Adj. EBITDAaL outlook . In addition, we now expect an improved outlook for Liberty Services & Corporate Adj. EBITDA of negative ~$175m for 2025 , driven by cost optimization initiatives." 4 4 2 Denver, Colorado: August 1, 2025 - Liberty Global Ltd. announces its Q2 2025 financial results. CEO Mike Fries stated, "In the second quarter, we continued to execute across our strategic pillars – Liberty Growth, Libe ...

Exhibit 99.1 Executing on mission to create and unlock value for Liberty shareholders Denver, Colorado: August 1, 2025 - Liberty Global Ltd. announces its Q2 2025 financial results. CEO Mike Fries stated, "In the second quarter, we continued to execute across our strategic pillars – Liberty Growth, Liberty Telecom and Liberty Services & Corporate, with an unwavering focus on creating and delivering value to shareholders. We are encouraged to see our strategy to unlock value succeeding, with Sunrise continui ...